Pier Capital, LLC Dexcom Inc Transaction History

Pier Capital, LLC

$670 Million
Q3 2024

A detailed history of Pier Capital, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Pier Capital, LLC holds 54 shares of DXCM stock, worth $4,064. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 54 -0.0%

Holding current value

$4,064

Previous $6,000 50.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$110.31 - $140.45 $2,316 - $2,949	-21 Reduced 28.0%	54 $6,000
Q1 2024 May 02, 2024	SELL	$114.22 - $140.1 $722,441 - $886,132	-6,325 Reduced 98.83%	75 $10,000
Q4 2023 Feb 15, 2024	BUY	$75.49 - $124.16 $130,446 - $214,548	1,728 Added 36.99%	6,400 $794,000
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $6,196 - $9,930	72 Added 1.57%	4,672 $435,000
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $78,504 - $91,424	-698 Reduced 13.17%	4,600 $591,000
Q1 2023 May 10, 2023	SELL	$104.0 - $122.92 $96,304 - $113,823	-926 Reduced 14.88%	5,298 $615,000
Q4 2022 Feb 15, 2023	BUY	$84.98 - $122.67 $528,915 - $763,498	6,224 New	6,224 $704,000
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $133,195 - $223,847	-2,125 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $15,627 - $24,731	327 Added 18.19%	2,125 $572,000
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $3,259 - $5,098	89 Added 5.21%	1,798 $393,000
Q3 2019 Nov 13, 2019	SELL	$35.53 - $43.8 $1,101 - $1,357	-31 Reduced 1.78%	1,709 $255,000
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $1,447 - $2,023	-52 Reduced 2.9%	1,740 $261,000
Q1 2019 Apr 24, 2019	SELL	$28.07 - $38.18 $45,389 - $61,737	-1,617 Reduced 47.43%	1,792 $213,000
Q4 2018 Feb 13, 2019	BUY	$26.99 - $37.37 $92,008 - $127,394	3,409 New	3,409 $408,000

Others Institutions Holding DXCM

# of Institutions

1,015

Shares Held

352M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier Capital, LLC with notifications on news.

Account